These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19796269)

  • 1. Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells.
    Tolar J; Hippen KL; Blazar BR
    Br J Haematol; 2009 Oct; 147(2):200-6. PubMed ID: 19796269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.
    Kim YJ; Broxmeyer HE
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):112-26. PubMed ID: 20727784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
    Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
    Front Immunol; 2019; 10():619. PubMed ID: 31001253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.
    Bassani B; Tripodo C; Portararo P; Gulino A; Botti L; Chiodoni C; Jachetti E; Bolli N; Ciciarello M; Joehrens K; Anagnostopoulos I; Na IK; Curti A; Colombo MP; Sangaletti S
    Front Immunol; 2021; 12():662048. PubMed ID: 34084166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.
    Brunstein CG; Miller JS; McKenna DH; Hippen KL; DeFor TE; Sumstad D; Curtsinger J; Verneris MR; MacMillan ML; Levine BL; Riley JL; June CH; Le C; Weisdorf DJ; McGlave PB; Blazar BR; Wagner JE
    Blood; 2016 Feb; 127(8):1044-51. PubMed ID: 26563133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells administered after liver transplantation prevent acute graft-versus-host disease in rats.
    Xia X; Chen W; Ma T; Xu G; Liu H; Liang C; Bai X; Zhang Y; He Y; Liang T
    Liver Transpl; 2012 Jun; 18(6):696-706. PubMed ID: 22344929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of graft-versus-host disease with immunomodulatory cells.
    Yu Q; Wang H; Zhang L; Wei W
    Int Immunopharmacol; 2021 Mar; 92():107349. PubMed ID: 33486323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune regulatory cell infusion for graft-versus-host disease prevention and therapy.
    Blazar BR; MacDonald KPA; Hill GR
    Blood; 2018 Jun; 131(24):2651-2660. PubMed ID: 29728401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.
    Brown JA; Boussiotis VA
    Clin Immunol; 2008 Jun; 127(3):286-97. PubMed ID: 18395491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD.
    Mendt M; Daher M; Basar R; Shanley M; Kumar B; Wei Inng FL; Acharya S; Shaim H; Fowlkes N; Tran JP; Gokdemir E; Uprety N; Nunez-Cortes AK; Ensley E; Mai T; Kerbauy LN; Melo-Garcia L; Lin P; Shen Y; Mohanty V; Lu J; Li S; Nandivada V; Wang J; Banerjee P; Reyes-Silva F; Liu E; Ang S; Gilbert A; Li Y; Wan X; Gu J; Zhao M; Baran N; Muniz-Feliciano L; Wilson J; Kaur I; Gagea M; Konopleva M; Marin D; Tang G; Chen K; Champlin R; Rezvani K; Shpall EJ
    Front Immunol; 2021; 12():631353. PubMed ID: 34017325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord blood-derived stromal cells prevent graft-versus-host disease in mice following haplo-identical stem cell transplantation.
    Hao L; Gao L; Chen XH; Zou ZM; Zhang X; Kong PY; Zhang C; Peng XG; Sun AH; Wang QY
    Cytotherapy; 2011 Jan; 13(1):83-91. PubMed ID: 20662609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.
    Lucchini G; Introna M; Dander E; Rovelli A; Balduzzi A; Bonanomi S; Salvadè A; Capelli C; Belotti D; Gaipa G; Perseghin P; Vinci P; Lanino E; Chiusolo P; Orofino MG; Marktel S; Golay J; Rambaldi A; Biondi A; D'Amico G; Biagi E
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1293-301. PubMed ID: 20350611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical cord blood-derived mesenchymal stem cells ameliorate graft-versus-host disease following allogeneic hematopoietic stem cell transplantation through multiple immunoregulations.
    Wu QL; Liu XY; Nie DM; Zhu XX; Fang J; You Y; Zhong ZD; Xia LH; Hong M
    J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):477-484. PubMed ID: 26223913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cell supported umbilical cord blood ex vivo expansion enhances regulatory T cells and reduces graft versus host disease.
    Fan X; Gay FP; Ong SY; Ang JM; Chu PP; Bari S; Lim TK; Hwang WY
    Cytotherapy; 2013 May; 15(5):610-9. PubMed ID: 23419678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation.
    Lee SH; Lee MW; Yoo KH; Kim DS; Son MH; Sung KW; Cheuh H; Choi SJ; Oh W; Yang YS; Koo HH
    Bone Marrow Transplant; 2013 Aug; 48(8):1040-5. PubMed ID: 23396407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.